Loading…

Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors

Successful lead optimization in structure‐based drug discovery depends on the correct deduction and interpretation of the underlying structure–activity relationships (SAR) to facilitate efficient decision‐making on the next candidates to be synthesized. Consequently, the question arises, how frequen...

Full description

Saved in:
Bibliographic Details
Published in:Angewandte Chemie International Edition 2015-02, Vol.54 (9), p.2849-2853
Main Authors: Kuhnert, Maren, Köster, Helene, Bartholomäus, Ruben, Park, Ah Young, Shahim, Amir, Heine, Andreas, Steuber, Holger, Klebe, Gerhard, Diederich, Wibke E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3
cites cdi_FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3
container_end_page 2853
container_issue 9
container_start_page 2849
container_title Angewandte Chemie International Edition
container_volume 54
creator Kuhnert, Maren
Köster, Helene
Bartholomäus, Ruben
Park, Ah Young
Shahim, Amir
Heine, Andreas
Steuber, Holger
Klebe, Gerhard
Diederich, Wibke E.
description Successful lead optimization in structure‐based drug discovery depends on the correct deduction and interpretation of the underlying structure–activity relationships (SAR) to facilitate efficient decision‐making on the next candidates to be synthesized. Consequently, the question arises, how frequently a binding mode (re)‐validation is required, to ensure not to be misled by invalid assumptions on the binding geometry. We present an example in which minor chemical modifications within one inhibitor series lead to surprisingly different binding modes. X‐ray structure determination of eight inhibitors derived from one core scaffold resulted in four different binding modes in the aspartic protease endothiapepsin, a well‐established surrogate for e.g. renin and β‐secretase. In addition, we suggest an empirical metrics that might serve as an indicator during lead optimization to qualify compounds as candidates for structural revalidation. Changing poses: The optimization of lead structures relies on the systematic variation of the substituents decorating a given hit scaffold which is based on one binding pose that is supposed to be invariable. For a given core scaffold, only minor chemical variations were found to result in four different binding modes. An indicative metric is suggested to assess candidates that qualify for structural revalidation.
doi_str_mv 10.1002/anie.201411206
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1700975602</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1657324674</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3</originalsourceid><addsrcrecordid>eNqF0b9vEzEcBfATAtFSWBmRJRYWB3_9844tRCWNFNoKFcFm-Xy-1u2dHWxHUP56LkqJEEsne_i8J1uvql4DmQEh9L0J3s0oAQ5AiXxSHYOggJlS7Ol054xhVQs4ql7kfDv5uibyeXVEhWSESziurq-SsT5co48-dLvzc-xcRj6gM19wiXjtTIcuNsWP_rcpPoYPaHFjRje4GPDa3zl0GfOUiD2a541JxVt0mWJxJju0Cje-9SWm_LJ61pshu1cP50n19dPp1eIMry-Wq8V8ja0EJbFrjaz7mpBOSWJaxkUjwPIeet4Ywqd3C8Z7WgOvqW0Jb6yVDNqGW1B911l2Ur3b925S_LF1uejRZ-uGwQQXt1mDIqRRQhL6OJVCMcql4hN9-x-9jdsUpo_slBCkoSAnNdsrm2LOyfV6k_xo0r0Gondr6d1a-rDWFHjzULttR9cd-N95JtDswU8_uPtH6vT8fHX6bzneZ30u7tcha9Kdloopob-dLzWlwL_UfKm_sz89H62d</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1655509216</pqid></control><display><type>article</type><title>Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Kuhnert, Maren ; Köster, Helene ; Bartholomäus, Ruben ; Park, Ah Young ; Shahim, Amir ; Heine, Andreas ; Steuber, Holger ; Klebe, Gerhard ; Diederich, Wibke E.</creator><creatorcontrib>Kuhnert, Maren ; Köster, Helene ; Bartholomäus, Ruben ; Park, Ah Young ; Shahim, Amir ; Heine, Andreas ; Steuber, Holger ; Klebe, Gerhard ; Diederich, Wibke E.</creatorcontrib><description>Successful lead optimization in structure‐based drug discovery depends on the correct deduction and interpretation of the underlying structure–activity relationships (SAR) to facilitate efficient decision‐making on the next candidates to be synthesized. Consequently, the question arises, how frequently a binding mode (re)‐validation is required, to ensure not to be misled by invalid assumptions on the binding geometry. We present an example in which minor chemical modifications within one inhibitor series lead to surprisingly different binding modes. X‐ray structure determination of eight inhibitors derived from one core scaffold resulted in four different binding modes in the aspartic protease endothiapepsin, a well‐established surrogate for e.g. renin and β‐secretase. In addition, we suggest an empirical metrics that might serve as an indicator during lead optimization to qualify compounds as candidates for structural revalidation. Changing poses: The optimization of lead structures relies on the systematic variation of the substituents decorating a given hit scaffold which is based on one binding pose that is supposed to be invariable. For a given core scaffold, only minor chemical variations were found to result in four different binding modes. An indicative metric is suggested to assess candidates that qualify for structural revalidation.</description><edition>International ed. in English</edition><identifier>ISSN: 1433-7851</identifier><identifier>EISSN: 1521-3773</identifier><identifier>DOI: 10.1002/anie.201411206</identifier><identifier>PMID: 25630461</identifier><identifier>CODEN: ACIEAY</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Aspartic Acid Endopeptidases - antagonists &amp; inhibitors ; Aspartic Acid Endopeptidases - chemical synthesis ; Aspartic Acid Endopeptidases - chemistry ; Aspartic Acid Endopeptidases - metabolism ; Aspartic Acid Endopeptidases - pharmacology ; Binding ; Binding Sites - drug effects ; Decision making ; Decoration ; Dose-Response Relationship, Drug ; drug design ; enzyme inhibitors ; Indicators ; Inhibitors ; ligand-enzyme binding ; Models, Molecular ; Molecular Structure ; Optimization ; Protease Inhibitors - chemical synthesis ; Protease Inhibitors - chemistry ; Protease Inhibitors - pharmacology ; Scaffolds ; structure determination ; Structure-Activity Relationship ; thermal shift assay (TSA) ; Thiophenes - chemical synthesis ; Thiophenes - chemistry ; Thiophenes - pharmacology ; X-rays</subject><ispartof>Angewandte Chemie International Edition, 2015-02, Vol.54 (9), p.2849-2853</ispartof><rights>2015 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>2015 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</rights><rights>2015 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3</citedby><cites>FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25630461$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kuhnert, Maren</creatorcontrib><creatorcontrib>Köster, Helene</creatorcontrib><creatorcontrib>Bartholomäus, Ruben</creatorcontrib><creatorcontrib>Park, Ah Young</creatorcontrib><creatorcontrib>Shahim, Amir</creatorcontrib><creatorcontrib>Heine, Andreas</creatorcontrib><creatorcontrib>Steuber, Holger</creatorcontrib><creatorcontrib>Klebe, Gerhard</creatorcontrib><creatorcontrib>Diederich, Wibke E.</creatorcontrib><title>Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors</title><title>Angewandte Chemie International Edition</title><addtitle>Angew. Chem. Int. Ed</addtitle><description>Successful lead optimization in structure‐based drug discovery depends on the correct deduction and interpretation of the underlying structure–activity relationships (SAR) to facilitate efficient decision‐making on the next candidates to be synthesized. Consequently, the question arises, how frequently a binding mode (re)‐validation is required, to ensure not to be misled by invalid assumptions on the binding geometry. We present an example in which minor chemical modifications within one inhibitor series lead to surprisingly different binding modes. X‐ray structure determination of eight inhibitors derived from one core scaffold resulted in four different binding modes in the aspartic protease endothiapepsin, a well‐established surrogate for e.g. renin and β‐secretase. In addition, we suggest an empirical metrics that might serve as an indicator during lead optimization to qualify compounds as candidates for structural revalidation. Changing poses: The optimization of lead structures relies on the systematic variation of the substituents decorating a given hit scaffold which is based on one binding pose that is supposed to be invariable. For a given core scaffold, only minor chemical variations were found to result in four different binding modes. An indicative metric is suggested to assess candidates that qualify for structural revalidation.</description><subject>Aspartic Acid Endopeptidases - antagonists &amp; inhibitors</subject><subject>Aspartic Acid Endopeptidases - chemical synthesis</subject><subject>Aspartic Acid Endopeptidases - chemistry</subject><subject>Aspartic Acid Endopeptidases - metabolism</subject><subject>Aspartic Acid Endopeptidases - pharmacology</subject><subject>Binding</subject><subject>Binding Sites - drug effects</subject><subject>Decision making</subject><subject>Decoration</subject><subject>Dose-Response Relationship, Drug</subject><subject>drug design</subject><subject>enzyme inhibitors</subject><subject>Indicators</subject><subject>Inhibitors</subject><subject>ligand-enzyme binding</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Optimization</subject><subject>Protease Inhibitors - chemical synthesis</subject><subject>Protease Inhibitors - chemistry</subject><subject>Protease Inhibitors - pharmacology</subject><subject>Scaffolds</subject><subject>structure determination</subject><subject>Structure-Activity Relationship</subject><subject>thermal shift assay (TSA)</subject><subject>Thiophenes - chemical synthesis</subject><subject>Thiophenes - chemistry</subject><subject>Thiophenes - pharmacology</subject><subject>X-rays</subject><issn>1433-7851</issn><issn>1521-3773</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqF0b9vEzEcBfATAtFSWBmRJRYWB3_9844tRCWNFNoKFcFm-Xy-1u2dHWxHUP56LkqJEEsne_i8J1uvql4DmQEh9L0J3s0oAQ5AiXxSHYOggJlS7Ol054xhVQs4ql7kfDv5uibyeXVEhWSESziurq-SsT5co48-dLvzc-xcRj6gM19wiXjtTIcuNsWP_rcpPoYPaHFjRje4GPDa3zl0GfOUiD2a541JxVt0mWJxJju0Cje-9SWm_LJ61pshu1cP50n19dPp1eIMry-Wq8V8ja0EJbFrjaz7mpBOSWJaxkUjwPIeet4Ywqd3C8Z7WgOvqW0Jb6yVDNqGW1B911l2Ur3b925S_LF1uejRZ-uGwQQXt1mDIqRRQhL6OJVCMcql4hN9-x-9jdsUpo_slBCkoSAnNdsrm2LOyfV6k_xo0r0Gondr6d1a-rDWFHjzULttR9cd-N95JtDswU8_uPtH6vT8fHX6bzneZ30u7tcha9Kdloopob-dLzWlwL_UfKm_sz89H62d</recordid><startdate>20150223</startdate><enddate>20150223</enddate><creator>Kuhnert, Maren</creator><creator>Köster, Helene</creator><creator>Bartholomäus, Ruben</creator><creator>Park, Ah Young</creator><creator>Shahim, Amir</creator><creator>Heine, Andreas</creator><creator>Steuber, Holger</creator><creator>Klebe, Gerhard</creator><creator>Diederich, Wibke E.</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>K9.</scope><scope>7X8</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope></search><sort><creationdate>20150223</creationdate><title>Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors</title><author>Kuhnert, Maren ; Köster, Helene ; Bartholomäus, Ruben ; Park, Ah Young ; Shahim, Amir ; Heine, Andreas ; Steuber, Holger ; Klebe, Gerhard ; Diederich, Wibke E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aspartic Acid Endopeptidases - antagonists &amp; inhibitors</topic><topic>Aspartic Acid Endopeptidases - chemical synthesis</topic><topic>Aspartic Acid Endopeptidases - chemistry</topic><topic>Aspartic Acid Endopeptidases - metabolism</topic><topic>Aspartic Acid Endopeptidases - pharmacology</topic><topic>Binding</topic><topic>Binding Sites - drug effects</topic><topic>Decision making</topic><topic>Decoration</topic><topic>Dose-Response Relationship, Drug</topic><topic>drug design</topic><topic>enzyme inhibitors</topic><topic>Indicators</topic><topic>Inhibitors</topic><topic>ligand-enzyme binding</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Optimization</topic><topic>Protease Inhibitors - chemical synthesis</topic><topic>Protease Inhibitors - chemistry</topic><topic>Protease Inhibitors - pharmacology</topic><topic>Scaffolds</topic><topic>structure determination</topic><topic>Structure-Activity Relationship</topic><topic>thermal shift assay (TSA)</topic><topic>Thiophenes - chemical synthesis</topic><topic>Thiophenes - chemistry</topic><topic>Thiophenes - pharmacology</topic><topic>X-rays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kuhnert, Maren</creatorcontrib><creatorcontrib>Köster, Helene</creatorcontrib><creatorcontrib>Bartholomäus, Ruben</creatorcontrib><creatorcontrib>Park, Ah Young</creatorcontrib><creatorcontrib>Shahim, Amir</creatorcontrib><creatorcontrib>Heine, Andreas</creatorcontrib><creatorcontrib>Steuber, Holger</creatorcontrib><creatorcontrib>Klebe, Gerhard</creatorcontrib><creatorcontrib>Diederich, Wibke E.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><jtitle>Angewandte Chemie International Edition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kuhnert, Maren</au><au>Köster, Helene</au><au>Bartholomäus, Ruben</au><au>Park, Ah Young</au><au>Shahim, Amir</au><au>Heine, Andreas</au><au>Steuber, Holger</au><au>Klebe, Gerhard</au><au>Diederich, Wibke E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors</atitle><jtitle>Angewandte Chemie International Edition</jtitle><addtitle>Angew. Chem. Int. Ed</addtitle><date>2015-02-23</date><risdate>2015</risdate><volume>54</volume><issue>9</issue><spage>2849</spage><epage>2853</epage><pages>2849-2853</pages><issn>1433-7851</issn><eissn>1521-3773</eissn><coden>ACIEAY</coden><abstract>Successful lead optimization in structure‐based drug discovery depends on the correct deduction and interpretation of the underlying structure–activity relationships (SAR) to facilitate efficient decision‐making on the next candidates to be synthesized. Consequently, the question arises, how frequently a binding mode (re)‐validation is required, to ensure not to be misled by invalid assumptions on the binding geometry. We present an example in which minor chemical modifications within one inhibitor series lead to surprisingly different binding modes. X‐ray structure determination of eight inhibitors derived from one core scaffold resulted in four different binding modes in the aspartic protease endothiapepsin, a well‐established surrogate for e.g. renin and β‐secretase. In addition, we suggest an empirical metrics that might serve as an indicator during lead optimization to qualify compounds as candidates for structural revalidation. Changing poses: The optimization of lead structures relies on the systematic variation of the substituents decorating a given hit scaffold which is based on one binding pose that is supposed to be invariable. For a given core scaffold, only minor chemical variations were found to result in four different binding modes. An indicative metric is suggested to assess candidates that qualify for structural revalidation.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>25630461</pmid><doi>10.1002/anie.201411206</doi><tpages>5</tpages><edition>International ed. in English</edition></addata></record>
fulltext fulltext
identifier ISSN: 1433-7851
ispartof Angewandte Chemie International Edition, 2015-02, Vol.54 (9), p.2849-2853
issn 1433-7851
1521-3773
language eng
recordid cdi_proquest_miscellaneous_1700975602
source Wiley-Blackwell Read & Publish Collection
subjects Aspartic Acid Endopeptidases - antagonists & inhibitors
Aspartic Acid Endopeptidases - chemical synthesis
Aspartic Acid Endopeptidases - chemistry
Aspartic Acid Endopeptidases - metabolism
Aspartic Acid Endopeptidases - pharmacology
Binding
Binding Sites - drug effects
Decision making
Decoration
Dose-Response Relationship, Drug
drug design
enzyme inhibitors
Indicators
Inhibitors
ligand-enzyme binding
Models, Molecular
Molecular Structure
Optimization
Protease Inhibitors - chemical synthesis
Protease Inhibitors - chemistry
Protease Inhibitors - pharmacology
Scaffolds
structure determination
Structure-Activity Relationship
thermal shift assay (TSA)
Thiophenes - chemical synthesis
Thiophenes - chemistry
Thiophenes - pharmacology
X-rays
title Tracing Binding Modes in Hit-to-Lead Optimization: Chameleon-Like Poses of Aspartic Protease Inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T01%3A04%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tracing%20Binding%20Modes%20in%20Hit-to-Lead%20Optimization:%20Chameleon-Like%20Poses%20of%20Aspartic%20Protease%20Inhibitors&rft.jtitle=Angewandte%20Chemie%20International%20Edition&rft.au=Kuhnert,%20Maren&rft.date=2015-02-23&rft.volume=54&rft.issue=9&rft.spage=2849&rft.epage=2853&rft.pages=2849-2853&rft.issn=1433-7851&rft.eissn=1521-3773&rft.coden=ACIEAY&rft_id=info:doi/10.1002/anie.201411206&rft_dat=%3Cproquest_cross%3E1657324674%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c6176-eba68f800d760ab345951c4f1f49a04256534f281482cb049cc631b94c17fddc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1655509216&rft_id=info:pmid/25630461&rfr_iscdi=true